Style | Citing Format |
---|---|
MLA | Varnoosfaderani NJ, Amiriardekani E. "Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors”." Korean Journal of Family Medicine, vol. 44, no. 1, 2023, pp. 66-67. |
APA | Varnoosfaderani NJ, Amiriardekani E (2023). Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors”. Korean Journal of Family Medicine, 44(1), 66-67. |
Chicago | Varnoosfaderani NJ, Amiriardekani E. "Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors”." Korean Journal of Family Medicine 44, no. 1 (2023): 66-67. |
Harvard | Varnoosfaderani NJ, Amiriardekani E (2023) 'Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors”', Korean Journal of Family Medicine, 44(1), pp. 66-67. |
Vancouver | Varnoosfaderani NJ, Amiriardekani E. Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors”. Korean Journal of Family Medicine. 2023;44(1):66-67. |
BibTex | @article{ author = {Varnoosfaderani NJ and Amiriardekani E}, title = {Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors”}, journal = {Korean Journal of Family Medicine}, volume = {44}, number = {1}, pages = {66-67}, year = {2023} } |
RIS | TY - JOUR AU - Varnoosfaderani NJ AU - Amiriardekani E TI - Critical Considerations Regarding the Article “Association Between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence Among Breast Cancer Survivors” JO - Korean Journal of Family Medicine VL - 44 IS - 1 SP - 66 EP - 67 PY - 2023 ER - |